ConvaTec Group Plc (CNVVF)
USD 2.89
(0.0%)
USD 2.89
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 262.7 Million USD | 41.24% |
| 2022 | 207.3 Million USD | 1.82% |
| 2021 | 203.6 Million USD | -3.51% |
| 2020 | 211 Million USD | 117.75% |
| 2019 | 96.9 Million USD | -62.65% |
| 2018 | 259.41 Million USD | -1.05% |
| 2017 | 262.18 Million USD | 45.4% |
| 2016 | 180.31 Million USD | -19.57% |
| 2015 | 224.2 Million USD | 2.42% |
| 2014 | 218.9 Million USD | -28.84% |
| 2013 | 307.6 Million USD | 6.07% |
| 2012 | 290 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 76.3 Million USD | 0.0% |
| 2024 Q1 | 76.3 Million USD | -51.67% |
| 2023 Q4 | 157.87 Million USD | 117.17% |
| 2023 FY | 292.78 Million USD | 41.24% |
| 2023 Q1 | 68.6 Million USD | -41.52% |
| 2023 Q2 | 134.83 Million USD | 96.56% |
| 2023 Q3 | 72.7 Million USD | -46.08% |
| 2022 FY | 207.3 Million USD | 1.82% |
| 2022 Q4 | 117.3 Million USD | 84.88% |
| 2022 Q3 | 63.45 Million USD | -38.29% |
| 2022 Q2 | 102.81 Million USD | 73.97% |
| 2022 Q1 | 59.1 Million USD | -23.92% |
| 2021 Q2 | 139.66 Million USD | 101.1% |
| 2021 FY | 203.6 Million USD | -3.51% |
| 2021 Q1 | 69.45 Million USD | -41.76% |
| 2021 Q3 | 46.2 Million USD | -66.92% |
| 2021 Q4 | 77.67 Million USD | 68.13% |
| 2020 FY | 211 Million USD | 117.75% |
| 2020 Q2 | 117.45 Million USD | 96.73% |
| 2020 Q3 | 52.75 Million USD | -55.09% |
| 2020 Q4 | 119.23 Million USD | 126.05% |
| 2020 Q1 | 59.7 Million USD | -53.88% |
| 2019 Q1 | 47.5 Million USD | -38.07% |
| 2019 FY | 96.9 Million USD | -62.65% |
| 2019 Q4 | 129.44 Million USD | 116.82% |
| 2019 Q3 | 59.7 Million USD | -36.12% |
| 2019 Q2 | 93.45 Million USD | 96.76% |
| 2018 Q2 | 63.7 Million USD | 0.0% |
| 2018 Q1 | 63.7 Million USD | -28.55% |
| 2018 FY | 259.41 Million USD | -1.05% |
| 2018 Q4 | 76.7 Million USD | 0.0% |
| 2018 Q3 | 76.7 Million USD | 20.41% |
| 2017 Q3 | 89.15 Million USD | 73.44% |
| 2017 Q2 | 51.4 Million USD | 0.0% |
| 2017 Q1 | 51.4 Million USD | -17.03% |
| 2017 Q4 | 89.15 Million USD | 0.0% |
| 2017 FY | 262.18 Million USD | 45.4% |
| 2016 Q3 | 61.95 Million USD | 192.22% |
| 2016 Q1 | 58.6 Million USD | -2.01% |
| 2016 Q4 | 61.95 Million USD | 0.0% |
| 2016 Q2 | 21.2 Million USD | -63.82% |
| 2016 FY | 180.31 Million USD | -19.57% |
| 2015 FY | 224.2 Million USD | 2.42% |
| 2015 Q4 | 59.8 Million USD | -16.48% |
| 2015 Q3 | 71.6 Million USD | 9.15% |
| 2015 Q2 | 65.59 Million USD | 8.61% |
| 2015 Q1 | 60.4 Million USD | 4.5% |
| 2014 Q1 | 61.4 Million USD | -37.79% |
| 2014 FY | 218.9 Million USD | -28.84% |
| 2014 Q2 | 83.9 Million USD | 36.64% |
| 2014 Q4 | 57.8 Million USD | -39.16% |
| 2014 Q3 | 95 Million USD | 13.23% |
| 2013 Q3 | 101.1 Million USD | 17.15% |
| 2013 Q2 | 86.3 Million USD | 47.02% |
| 2013 FY | 307.6 Million USD | 6.07% |
| 2013 Q4 | 98.7 Million USD | -2.37% |
| 2013 Q1 | 58.7 Million USD | -54.78% |
| 2012 Q4 | 129.8 Million USD | 105.71% |
| 2012 Q3 | 63.1 Million USD | 0.0% |
| 2012 FY | 290 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -22464.464% |
| Ansell Limited | 129.3 Million USD | -103.171% |
| Ansell Limited | 129.3 Million USD | -103.171% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | -743.659% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 16562.984% |
| Psykey, Inc. | -797.5 Thousand USD | 33040.274% |
| ConvaTec Group Plc | 262.7 Million USD | 0.0% |
| Encision Inc. | -640.78 Thousand USD | 41096.718% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 185347.867% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 239070.254% |
| Innovative MedTech Inc. | -4.27 Million USD | 6246.358% |
| LifePoint, Inc. | -7.49 Million USD | 3604.897% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 4154.012% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -79506.061% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 213868.411% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 56319.21% |
| SmileDirectClub, Inc. | -241.15 Million USD | 208.934% |
| Sector 10, Inc. | -39.84 Thousand USD | 659421.353% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 17.805% |
| SheerVision, Inc. | 155.72 Thousand USD | -168593.731% |
| United Health Products, Inc. | -2.42 Million USD | 10926.119% |
| Vasamed, Inc. | 4.74 Million USD | -5439.504% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 11550.909% |
| Yubo International Biotech Limited | -1.2 Million USD | 21896.796% |